I’ve Reviewed Many Patent Portfolios. Here’s What Makes One Worth $100M
I Once Represented a Company That Had Nothing but Patents
They sued major industry players who refused to settle. Those companies responded by filing reexaminations on every asserted patent.
We defended them successfully.
The result?
A licensing deal worth over $100 million.
Their valuation jumped overnight.
But here’s what actually made those patents valuable:
✔ Strategic claim drafting from day one
✔ Every independent claim captured a key inventive feature
✔ Every patent was filed with leverage in mind
Most founders never get there.
Instead, they accumulate patents the way people collect business cards at conferences—reactive, unfocused, and ultimately useless when it matters.
Large patent portfolios, even those with 50+ patents, do not necessarily confer competitive advantage.
The determining factor is strategy, not quantity.
Patents Are Static. Your Product Isn’t.
Here’s the trap I see constantly.
A founder files a patent.
It gets granted.
They move on.
The patent sits in a portfolio somewhere, slowly becoming irrelevant as the product evolves.
Patents capture your product at a single point in time. They document what you built—maybe a few variations—and that’s it.
Meanwhile, your product changes every quarter based on:
✔ Customer feedback
✔ Market demands
✔ Competitive pressure
A patent strategy that was valuable three years ago may have little—or no—value today if your product has evolved beyond what those claims actually cover.
This is the “file‑and‑forget” problem.
✔ It’s expensive
✔ It looks good in investor decks
✔ It creates zero leverage when you actually need it
The alternative?
A patent strategy that evolves with your product roadmap.
The Six Questions I Ask Before Any Founder Files
Before we talk about filing anything, I run founders through a diagnostic framework. These questions separate strategic patents from expensive paperwork.
1. What Is the Primary Business Objective?
✔ Market control
✔ Increasing valuation
✔ Attracting investors
✔ Licensing optionality
✔ Competitive deterrence
Patents are tools, not trophies.
Different objectives require fundamentally different strategies. Claim scope, filing jurisdictions, portfolio structure, and budget all change depending on what you’re actually trying to accomplish.
Without clarity here, filings tend to be unfocused and fail to create leverage during fundraising, partnerships, or exit conversations.
2. Have You Publicly Used, Shown, Sold, or Disclosed the Invention?
Public disclosure is the single biggest hidden risk in patent strategy.
I recently spoke with a founder building a home‑improvement tool. During our strategy session, I learned the product had been publicly displayed and sold more than a year earlier, with no meaningful improvements since.
U.S. patent protection was impossible.
My advice:
✔ Forget the patent
✔ Focus on first‑mover advantage and name recognition
Yes, competitors may enter the space and benefit from your success. But you still retain a head start and the opportunity to capture meaningful market share.
Demos, pilots, customer trials, press releases, conference talks—any of these can destroy patent rights or force rushed, weak filings. This question determines urgency and filing type.
3. What Technical Aspects Actually Create Market Advantage?
Not every technical feature is worth patenting.
Strong patents protect leverage points—architectures, workflows, and system‑level advantages that competitors can’t easily avoid.
This question separates:
✔ “Interesting technology”
✔ “Strategically protectable value”
Research consistently shows that a small number of high‑quality patents outperform large portfolios. Patent quality is the new gold standard.
4. Who Are the Current and Future Competitors?
Patent strategy doesn’t exist in a vacuum.
Understanding competitors:
✔ Shapes claim breadth
✔ Reveals white space
✔ Determines whether patents will actually influence behavior
Sometimes your product doesn’t change—but competitor movement creates opportunity.
Example:
✔ A competitor moves into a space with little or no patent coverage
✔ A few strategic patents there can become a licensing gold mine later
5. What Are the Most Realistic Design‑Arounds?
If competitors can easily design around your patent, it won’t provide leverage—even if it’s granted.
As seasoned patent attorneys, we’re trained to identify design‑arounds. I raise this question in every IP strategy session because it forces founders to think like competitors.
Often the response is:
✔ “That alternative is possible.”
✔ “It’s not our current implementation—but it’s worth protecting.”
This mindset improves claim drafting and reveals whether broader protection is achievable.
6. How Does Timing Align With the Business?
Timing drives everything:
✔ When to file
✔ What to file
✔ How much to invest
A patent strategy misaligned with product launches or fundraising milestones often fails during diligence.
This question ensures IP strategy evolves in lockstep with business reality, not after the fact.
When a Patent Isn’t the Answer
Not every innovation should be patented.
I once advised a founder whose idea was best protected as a trade secret. Reverse engineering wasn’t feasible.
✔ Trade secrets are cheaper
✔ They last as long as secrecy is maintained
✔ Patents are expensive and expire after 20 years
Sometimes, the smartest move is not filing at all.
Research shows firms face a real trade‑off between quantity and quality. The reactive, invention‑driven approach leads to low‑value patents—often covering technology that never even ships.
Type A vs. Type B Founders
Type A founders treat IP like a checkbox.
✔ They file when investors ask
✔ They accumulate patents without revisiting alignment
Type B founders treat IP as a living strategy.
✔ They keep counsel informed of the product roadmap
✔ They involve IP early in product planning
✔ They conduct quarterly portfolio reviews as competitors and markets evolve
Type B founders understand that patents are about framing. When done strategically, patents tell a story of defensibility that elevates conversations around funding, valuation, and exits.
The 18‑Month Product Vision Framework
Here’s the process I use with strategic founders:
✔ Step 1: Map the roadmap
Define the next 18 months and identify where patents could matter.
✔ Step 2: Strategic advantage filter
If a filing doesn’t support a business objective, drop it.
✔ Step 3: Focused patentability search
Understand the landscape before investing.
✔ Step 4: Post‑search filter
If meaningful protection isn’t achievable, drop it. If it is, proceed.
✔ Step 5: Continuous review
Adjust strategy as the product and competitive landscape evolve.
This double‑filter approach prevents the accumulation of decorative patents.
What Leverage Actually Looks Like
Strategic IP work creates your investor narrative.
When patents are designed intentionally, you’ve already answered the hard questions:
✔ What is being protected—and why?
✔ Where does protection matter?
✔ How does it block competitors?
✔ What strategic value does it support?
When diligence gets tough, you’re prepared—not reactive.
That credibility differentiates you from founders who treat patents as a checkbox.
The Quality Problem Nobody Talks About
Large patent portfolios often mask low relevance.
Research shows that volume does not equal impact. Companies with massive portfolios can still struggle to raise capital or improve valuation if their patents don’t protect core technology or constrain competitors.
A simple test applies:
✔ If a patent doesn’t change anyone’s behavior—competitors, investors, or acquirers—it isn’t defensive
✔ It’s decorative
The Real Question
Most founders ask:
✔ “How many patents do we have?”
The real question is:
✔ Does each patent create leverage?
Strategic patents read on competitor behavior, not just your own product.
Quantity without strategy is just expensive paperwork.
The companies that win treat patents as living strategy—reviewed regularly, aligned with the roadmap, and designed to matter when it counts.
That’s the difference between a portfolio that looks good in a deck and one that supports a nine‑figure licensing deal.
